Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 65.25% | -242.27% | -104.52% | -25.00% | -1,140.00% |
| Total Depreciation and Amortization | 7.08% | -32.47% | 44.25% | 3.26% | 8.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.44% | 190.39% | -11.88% | 48.86% | -41.85% |
| Change in Net Operating Assets | -80.63% | -11.70% | -31.16% | 42.97% | 42.62% |
| Cash from Operations | -94.61% | 70.86% | -21.26% | 103.44% | -34.98% |
| Capital Expenditure | -1.79% | -10.40% | 24.91% | -28.10% | -6.06% |
| Sale of Property, Plant, and Equipment | 336.36% | -- | -- | -100.00% | -- |
| Cash Acquisitions | 49.77% | -229.32% | 87.33% | -284.62% | -75.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -400.00% | -3.57% | 61.11% | 20.00% | -26.76% |
| Cash from Investing | 31.60% | -125.20% | 79.68% | -193.74% | -43.03% |
| Total Debt Issued | -19.67% | 57.90% | -84.73% | 472.94% | -72.78% |
| Total Debt Repaid | 30.03% | -26.30% | 84.18% | -610.15% | 82.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.23% | -16.46% | 31.83% | -47.04% | 21.62% |
| Cash from Financing | -37.08% | 757.53% | -103.85% | 498.11% | 171.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -184.28% | 474.70% | -70.67% | 364.49% | 73.32% |